Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Potential pharmaceutical drugs in the field of cancer

27.12.2005


Raquel Villar Becares, in her PhD thesis at the Public University of Navarre, has developed new derivatives of benzo[b]tiophene 1,1-dioxide that enable their application in the pharmaceutical field. Moreover, the researcher tested for the antitumoural activity of these derivatives, concluding that 23 of the 24 compounds analysed proved to be active or very active against one or more of the tumoural cell lines tested.



Treatment of diabetes or high blood pressure

Although benzo[b]tiophene 1,1-dioxide, found in both crude and processed petroleum oil, was first described in 1893, it was not until the 1950s when it was discovered that the benzo[b]tiophene ring and its derivatives had interesting biological activities for possible use as pesticides, plant growth regulators, analgesics and local anaesthetics and antihistamines, amongst others applications.


In the field of medicine, a bright future is predicted for the possible application of these benzotiophene derivatives as antineoplasic agents. In order to enhance their properties as potential pharmaceutical drugs and to make progress in establishing their mode of action, thus, it was necessary to extend the number of known benzo[b]tiophene derivatives. All this with the end aim of exploring possibilities for their application in the pharmaceutical field as anti-cancer drugs.

The PhD proposed a rational design based on various theoretical methods, thrown up by the new derivatives, the activity of which was subsequently tested. In a parallel manner and, as knowledge was gained about their possible mechanism, Raquel Villar proposed the investigation of possible targets using theoretical docking methods on the protein active structure sites. Subsequently, they were evaluated as cytotoxic agents, tNOX inhibitors and carbonic anhydrase inhibitors.

Anti-tumoural activity

The activity of these new derivatives was tested, concluding that 23 of the 24 compounds analysed proved to be active or very active against one or more tumoural cell lines tested. Thus, the in vitro cytotoxic activity of 24 new derivatives of benzo[b]tiophene 1,1-dioxide were determined for activity against, amongst others: human lung and leukemia fibroblasts.

More specifically, a number of compounds had an in vitro cytotoxicity comparable to the commercial antineoplasic, Doxorrubicina, used as a positive control of activity in the trials carried out for tumoural growth inhibition.

Garazi Andonegi | alfa
Further information:
http://www.basqueresearch.com/berria_irakurri.asp?Gelaxka=1_1&hizk=I&Berri_Kod=843

More articles from Life Sciences:

nachricht Multi-institutional collaboration uncovers how molecular machines assemble
02.12.2016 | Salk Institute

nachricht Fertilized egg cells trigger and monitor loss of sperm’s epigenetic memory
02.12.2016 | IMBA - Institut für Molekulare Biotechnologie der Österreichischen Akademie der Wissenschaften GmbH

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

Im Focus: Molecules change shape when wet

Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water

In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...

Im Focus: Fraunhofer ISE Develops Highly Compact, High Frequency DC/DC Converter for Aviation

The efficiency of power electronic systems is not solely dependent on electrical efficiency but also on weight, for example, in mobile systems. When the weight of relevant components and devices in airplanes, for instance, is reduced, fuel savings can be achieved and correspondingly greenhouse gas emissions decreased. New materials and components based on gallium nitride (GaN) can help to reduce weight and increase the efficiency. With these new materials, power electronic switches can be operated at higher switching frequency, resulting in higher power density and lower material costs.

Researchers at the Fraunhofer Institute for Solar Energy Systems ISE together with partners have investigated how these materials can be used to make power...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

UTSA study describes new minimally invasive device to treat cancer and other illnesses

02.12.2016 | Medical Engineering

Plasma-zapping process could yield trans fat-free soybean oil product

02.12.2016 | Agricultural and Forestry Science

What do Netflix, Google and planetary systems have in common?

02.12.2016 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>